Epidemiological, Serological, and Entomological Investigation of New Visceral Leishmaniasis Foci in Nepal
The American Journal of Tropical Medicine and Hygiene · 2024
DOI: 10.4269/ajtmh.23-0373 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2024. Verfasst von Anand Ballabh Joshi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Public Health and Infectious Disease Research Center (PHIDReC), Kathmandu, Nepal. Hauptthemen laut MEDLINE: Leishmaniasis, Visceral, Phlebotomus, Psychodidae. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization.
Abstract (Originalsprache)
The aim of this study was to explore epidemiological, serological, entomological, and social aspects of visceral leishmaniasis (VL) in new foci in Nepal. The study was conducted in 11 villages of five districts that had been previously free of VL but that reported new cases between 2019 and 2021. We screened 1,288 inhabitants using rK39 tests and investigated the epidemiological and clinical characteristics of 12 recent VL cases. A total of 182 community members were interviewed about knowledge, attitude, and practices regarding VL. They then underwent an awareness training; 40 of them had a second interview at 6 months to assess the training impact. Vector surveys were conducted in six houses per village to assess sandfly density and infection rates. The prevalence of VL infection was 0.5% and 3.2% among screened populations in Dolpa and Kavre districts, respectively, while the other districts had no rK39-positive cases. No association between travel history and VL infection was found. Phlebotomus argentipes sandflies were collected in three districts at high altitudes (from 1,084 to 4,450 m). None of the sandflies captured had Leishmania donovani DNA. People in new foci were not aware of VL symptoms, vectors, or preventive measures. The training significantly improved their knowledge and practice in seeking medical care in case of illness. The epidemiological, serological, and entomological investigations suggest indigenous focal transmission of VL. An integrated package of strategic interventions should be implemented by the national VL elimination program in districts with new VL foci.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Public Health and Infectious Disease Research Center (PHIDReC), Kathmandu, Nepal.
- Central Department of Microbiology, Tribhuvan University, Kirtipur, Kathmandu, Nepal.
- UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), Geneva, Switzerland.
- Epidemiology and Disease Control Division, Department of Health Services, Teku, Kathmandu, Nepal.
- Centre for Medicine and Society, Albert-Ludwigs-University, Freiburg, Germany.
Förderung
- World Health Organization
Zitieren
APA
Joshi, A. B., Banjara, M. R., Das, M. L., Ghale, P., Pant, K. R., Pyakurel, U. R., Dahal, G., Paudel, K. P., Das, C. L., Kroeger, A., & Aseffa, A. (2024). Epidemiological, Serological, and Entomological Investigation of New Visceral Leishmaniasis Foci in Nepal. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.23-0373
Vancouver
Joshi AB, Banjara MR, Das ML, Ghale P, Pant KR, Pyakurel UR, et al. Epidemiological, Serological, and Entomological Investigation of New Visceral Leishmaniasis Foci in Nepal. The American Journal of Tropical Medicine and Hygiene. 2024. doi:10.4269/ajtmh.23-0373
BibTeX
@article{Joshi2024,
author = {Joshi, Anand Ballabh and Banjara, Megha Raj and Das, Murari Lal and Ghale, Pragyan and Pant, Krishna Raj and Pyakurel, Uttam Raj and Dahal, Gokarna and Paudel, Krishna Prasad and Das, Chuman Lal and Kroeger, Axel and Aseffa, Abraham},
title = {Epidemiological, Serological, and Entomological Investigation of New Visceral Leishmaniasis Foci in Nepal},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2024},
doi = {10.4269/ajtmh.23-0373}
}
EUVIMED